These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8286515)

  • 1. Comparison of HA-1A and E5 monoclonal antibodies to endotoxin in rats with endotoxaemia.
    Boom SJ; Davidson JA; Zhang P; Reidy J; Ramsay G
    Eur J Surg; 1993 Oct; 159(10):559-61. PubMed ID: 8286515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.
    Opal SM; Palardy JE; Parejo N; Jasman RL
    Crit Care Med; 2003 Mar; 31(3):929-32. PubMed ID: 12627007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis.
    Buttenschoen K; Berger D; Hiki N; Buttenschoen DC; Vasilescu C; Chikh-Torab F; Seidelmann M; Beger HG
    Eur J Surg; 2000 Jun; 166(6):459-66. PubMed ID: 10890542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a recombinant endotoxin-neutralizing protein with a human monoclonal antibody to endotoxin for the treatment of Escherichia coli sepsis in rats.
    Kuppermann N; Nelson DS; Saladino RA; Thompson CM; Sattler F; Novitsky TJ; Fleisher GR; Siber GR
    J Infect Dis; 1994 Sep; 170(3):630-5. PubMed ID: 8077721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide.
    Bogard WC; Siegel SA; Leone AO; Damiano E; Shealy DJ; Ely TM; Frederick B; Mascelli MA; Siegel RC; Machielse B
    J Immunol; 1993 May; 150(10):4438-49. PubMed ID: 7683319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.
    Rogy MA; Moldawer LL; Oldenburg HS; Thompson WA; Montegut WJ; Stackpole SA; Kumar A; Palladino MA; Marra MN; Lowry SF
    Ann Surg; 1994 Jul; 220(1):77-85. PubMed ID: 8024362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of binding specificity and the function of two human IgM anti-lipid A monoclonal antibodies.
    Wisniewski MA; Kazemi M; Fang IS; Knight LS; Huntenburg CC; Bubbers JE; Schneidkraut MJ
    Circ Shock; 1994 Dec; 44(4):230-7. PubMed ID: 7543030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
    JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-endotoxin monoclonal antibodies.
    Warren HS; Danner RL; Munford RS
    N Engl J Med; 1992 Apr; 326(17):1153-7. PubMed ID: 1552919
    [No Abstract]   [Full Text] [Related]  

  • 12. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-lipid A monoclonal antibody (E5) on microcirculatory function during lipopolysaccharide shock.
    Schwartz RW; Arden WA; Pofahl W; Derbin M; Oremus R; Greenberg RN; Gross DR
    J Surg Res; 1993 May; 54(5):474-9. PubMed ID: 8361172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cardiovascular effects of endotoxaemia by monoclonal antibodies specific for core endotoxin.
    Reidy J; Wright I; Boom SJ; Barclay R; Di Padova F; Ramsay G
    Br J Surg; 1992 Oct; 79(10):1087-90. PubMed ID: 1422729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of endotoxin and antiendotoxin antibodies in patients with multiple injuries: a prospective clinical study.
    Buttenschoen K; Berger D; Hiki N; Strecker W; Seidelmann M; Beger HG
    Eur J Surg; 1996 Nov; 162(11):853-60. PubMed ID: 8956953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of lipopolysaccharide core types among avian pathogenic Escherichia coli in relation to the major phylogenetic groups.
    Dissanayake DR; Wijewardana TG; Gunawardena GA; Poxton IR
    Vet Microbiol; 2008 Dec; 132(3-4):355-63. PubMed ID: 18597955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endotoxin-neutralizing capacity of serum from cardiac surgical patients.
    Bennett-Guerrero E; Barclay GR; Weng PL; Bodian CA; Feierman DE; Vela-Cantos F; Mythen MG
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):451-4. PubMed ID: 11505348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
    Koganei S; Ito M; Yamamoto K; Matsumoto N
    Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide.
    Müller-Loennies S; Brade L; Brade H
    Int J Med Microbiol; 2007 Sep; 297(5):321-40. PubMed ID: 17544324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.